Colchicine is a medicine used to treat gout, which is a painful type of arthritis. It works by reducing inflammation in the joints. It's sometimes used for other conditions too, but its main use is for gout.
Every report comes from a Lived member, sent anonymously.
Have you tried Colchicine for Gout?
Colchicine is a prescription anti-inflammatory medicine best known for treating and preventing gout flares. Gout is a type of arthritis in which uric acid crystals build up in a joint and set off sudden attacks of pain, redness and swelling. Taken at the first sign of a flare, colchicine can shorten the attack. Taken daily at a low dose, it helps prevent flares, especially in the first months after starting a uric acid-lowering medicine such as allopurinol, a period when flares often become more frequent before they settle. It is also approved for familial Mediterranean fever (FMF), an inherited condition that causes repeated bouts of fever and painful inflammation, in adults and children 4 and older. Colchicine is sold in several forms. The 0.6 mg tablets (Colcrys and generics) are used for gout and FMF; 0.6 mg capsules (Mitigare and generics) are approved only for preventing gout flares; and Gloperba is a liquid approved, like the capsules, only for preventing gout flares in adults. A separate 0.5 mg tablet, Lodoco, is approved for a different purpose: lowering the risk of heart attack, stroke, the need for procedures to reopen heart arteries, and death from heart disease in adults who have narrowed arteries or several risk factors for heart disease. These products differ in strength and purpose, so one should not be swapped for another without the prescriber's guidance. Doctors also use colchicine off-label to treat pericarditis, inflammation of the sac around the heart, where it lowers the chance that the inflammation returns. Colchicine is not a general painkiller. It calms a specific kind of inflammation and does nothing for pain from other causes.
Many of colchicine's effects come from how it acts on white blood cells called neutrophils, which rush into a joint when uric acid crystals form and drive much of the pain and swelling of a gout attack. Colchicine binds to tubulin, the building block of tiny internal scaffolding structures called microtubules. Without working microtubules, neutrophils cannot move into the joint or release their inflammatory contents as effectively. Colchicine also appears to interfere with the inflammasome, a cellular switch that triggers a powerful inflammatory signal called interleukin-1. This explains why it helps in gout, FMF, pericarditis and the low-grade inflammation inside diseased heart arteries, all of which involve this kind of immune activity. It does not lower uric acid, so it does not treat the underlying cause of gout. It also does not block pain signals, which is why it does not work as a general painkiller.
Colchicine is taken by mouth, with or without food. The dose depends on what it is treating, as well as age, kidney and liver function, and other medicines. For a gout flare, the standard approach is a small dose started at the first sign of the attack: two 0.6 mg tablets, followed by one more tablet an hour later. This is one course per flare, not repeated the next day unless the prescriber says so, and people who already take daily colchicine follow their prescriber's plan for when to restart the daily dose. Taking more does not work better; in the trial behind this dosing, a higher regimen caused far more diarrhea and vomiting without extra benefit. Starting early matters, so many people with gout keep a supply on hand with a clear plan from their prescriber. For preventing flares, adults usually take 0.6 mg once or twice a day. FMF doses are higher and adjusted gradually. Lodoco is a single 0.5 mg tablet once a day. If a daily dose is missed, take it when remembered and return to the usual schedule, but never double the next dose. Because doses that are safe on their own can become dangerous when another medicine raises colchicine levels, prescribers may lower the dose or pause colchicine during treatment with certain drugs.
Diarrhea, nausea, stomach cramps and vomiting are the most common side effects. At the recommended flare dose they are often mild, and in the main gout trial the rate was only modestly higher than with placebo. Severe or persistent diarrhea or vomiting matters more with colchicine than with many drugs, because it can be an early sign that the drug is building up to toxic levels. Contact the prescriber promptly if this happens. Mild muscle aches are slightly more common with long-term use, but new, worsening or unexplained muscle pain or weakness should not be assumed to be these mild aches and needs the action described below. Two less common problems need attention. Colchicine can damage muscles and nerves, especially with long-term use, in older adults, in people with kidney disease, or alongside statins or certain other medicines. Muscle pain or weakness, or tingling or numbness in the fingers or toes, means stop colchicine and get medical evaluation right away. Colchicine can also, rarely, suppress the bone marrow and lower the counts of the blood cells that fight infection and help blood clot, one reason blood tests may be part of long-term treatment.
Colchicine's most serious risks come from interactions. The body clears it through liver enzymes and a drug-transport pump, and medicines that block these can raise colchicine to dangerous or fatal levels. Deaths have been reported with the antibiotic clarithromycin and with cyclosporine, an immune-suppressing drug used after organ transplants. Some antifungal medicines (such as itraconazole and ketoconazole) and many HIV medicines are also strong blockers. Lodoco should not be taken with these strong blockers by anyone, and people with kidney or liver impairment should not take any form of colchicine with them. The blood pressure and heart rhythm drugs diltiazem and verapamil raise colchicine levels less strongly: the colchicine dose may need to be lower and the person should watch for signs of toxicity, while people with kidney or liver impairment generally avoid the combination. Do not stop a heart medicine or colchicine on your own because of an interaction; the prescriber can adjust the plan. Check with the prescriber or pharmacist before starting any new medicine, especially an antibiotic, and avoid grapefruit and grapefruit juice, which act on the same pathway. Statins (cholesterol drugs) and fibrates (medicines that mainly lower triglycerides, a type of blood fat) such as gemfibrozil and fenofibrate can add to colchicine's muscle risk. They are often taken together, particularly with Lodoco, but warrant watching for muscle symptoms. Kidney and liver disease slow the removal of colchicine and raise the risk of toxicity, so dosing may change and monitoring is closer. Lodoco is not used in people with kidney failure, severe liver impairment, or an existing blood disorder. Colchicine overdose can be fatal, and there is no antidote. Keep it out of reach of children. If a child swallows colchicine or someone takes more than prescribed, call Poison Control (1-800-222-1222) or get emergency care right away, even before symptoms appear, because the most serious effects can develop one to three days later. Colchicine crosses the placenta. Studies of people taking it for FMF during pregnancy have not shown an increase in miscarriage or birth defects, but anyone pregnant or planning pregnancy should review the benefits and risks with their prescriber.
For a gout flare, colchicine is meant to be started at the first sign of an attack, which is why a written plan and a supply on hand help. Some people need a different flare treatment, such as an anti-inflammatory painkiller (NSAID) or a steroid, if colchicine does not suit them. When colchicine is used to prevent flares while starting a uric acid-lowering medicine, it is usually continued for at least three to six months, because flares often return if it is stopped too soon. The long-term solution for frequent gout is getting uric acid down; colchicine bridges the gap. In FMF, it is a long-term daily treatment that reduces attacks. With Lodoco, there is nothing to feel: the benefit is fewer heart events over years. In the main trial, about 7 in 100 people taking it had a major heart event over roughly two and a half years, compared with about 10 in 100 on placebo, on top of statins and other standard heart medicines rather than instead of them. Follow-up may include kidney and liver tests and blood counts, particularly with long-term use, older age or other medicines that interact. Any change in medicines is a good moment to recheck whether the colchicine dose still fits.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Colchicine, what you've noticed, or ask the community a question.